| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/29/2006 | EP1409539B1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 03/29/2006 | EP1395563B1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 03/29/2006 | EP1379253B1 Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/29/2006 | EP1379234B1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 03/29/2006 | EP1079847B1 Osteoporosis treatment |
| 03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
| 03/29/2006 | EP0948541B1 Analogs of PTHrP |
| 03/29/2006 | CN1753904A Bmp-2 estrogen responsive element and methods of using the same |
| 03/29/2006 | CN1753896A Novel compounds and uses thereof |
| 03/29/2006 | CN1753694A Remedy for spinal injury containing interleukin-6 antagonist |
| 03/29/2006 | CN1752103A Bone pattern generation protein 2 active peptide and its preparation method and application |
| 03/29/2006 | CN1752085A Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 03/29/2006 | CN1751740A Medicinal composition for treating arthritis |
| 03/29/2006 | CN1751738A Traditional Chinese medicine Babuji for treating arthritis, omitis and hyperosteogeny and its prepn. method |
| 03/29/2006 | CN1751726A Fine spike acanthaceous external use medicine |
| 03/29/2006 | CN1751709A External use medicine for treating traumatic injury |
| 03/29/2006 | CN1751699A Sofflower injection and its prepn. method |
| 03/29/2006 | CN1751695A Traditional Chinese medicine for treating bone injury |
| 03/29/2006 | CN1751690A Compound injection contg. alendronate sodium and vitamin D3 |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247586C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247573C Method for preparing arylacetyl aminothiazole |
| 03/29/2006 | CN1247570C Novel pyridyl cyanoguandine compounds |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/29/2006 | CN1247260C Analogs of parathyroid hormone |
| 03/29/2006 | CN1247252C Blood stasis eliminating powder |
| 03/29/2006 | CN1247238C Chinese medicine ointment for curing hyperosteogeny, pain and numbness and its production method |
| 03/29/2006 | CN1247235C Chinese medicinal herb paste for treating traumatic injury |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/28/2006 | USRE39050 Treating post-menopausal osteoporosis with raloxifene, formerly keoxifene, or raloxifene hydrochloride; new usage |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019030 Immunotherapeutic agents |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018982 Methods useful in the treatment of bone resorption diseases |
| 03/28/2006 | US7018810 Chordin-like molecules and uses thereof |
| 03/28/2006 | US7018797 Method for treating neurodegenerative disorders |
| 03/28/2006 | US7018662 Palliative effects of morinda citrifolia oil and juice |
| 03/28/2006 | US7018637 Vaccines; immunology carrier containing epitope binding tocarbohydrates |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/23/2006 | WO2006032042A2 Us of cntf or a cntf derivative in combination with a further compound for the preparation of medicament for the treatment of obesity |
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031376A2 Use of antioxidants for treating degenerative disc disease |
| 03/23/2006 | WO2006030805A1 Triazole derivative or salt thereof |
| 03/23/2006 | WO2006030803A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 03/23/2006 | WO2006030285A1 New 1,2,4-triazole-3-carboxamide derivatives |
| 03/23/2006 | WO2005112542A3 Cartilage and bone repair composition |
| 03/23/2006 | US20060063944 Estrone derivatives and process for producing same |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060062771 Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor |
| 03/23/2006 | DE19723155B4 Verwendung eines Eisensalzes der Alginsäure zur Therapie rheumatischer Erkrankungen Use of an iron salt of alginic acid for the treatment of rheumatic diseases |
| 03/23/2006 | DE102004045720A1 Stabile Dosierungsform von Phenylalanin-Derivaten Stable dosage form of phenylalanine derivatives |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580409A1 Triazole derivative or salt thereof |
| 03/23/2006 | CA2580236A1 Purinenucleoside derivative modified in 8-position and medical use thereof |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637159A1 Immunocompetent cell activation inhibitor and use thereof |
| 03/22/2006 | EP1637151A1 Preventive or remedy for arthritis |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1636270A2 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 03/22/2006 | EP1636212A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 03/22/2006 | EP1635791A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation |
| 03/22/2006 | EP1538927A4 Fruit and/or vegetable derived composition |
| 03/22/2006 | EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1406891B1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1221963A4 Methods of inhibiting osteoclastogenesis |
| 03/22/2006 | EP1179008B1 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0914456B1 Gene expression in monocytes and macrophages |
| 03/22/2006 | CN1750762A Composition containing isoflavone of high purity at high concentration and process for producing the same |
| 03/22/2006 | CN1749262A Process for preparing flaxseed lignan total glycoside extract and use thereof |
| 03/22/2006 | CN1748787A Pharmaceutical preparation containing p40 molecule or its gene |
| 03/22/2006 | CN1748778A Plaster for bone setting and removing stagnation |
| 03/22/2006 | CN1748767A Lupus preparation and new preparing method |